Compare

Oscar Health/$OSCR

1D1W1M3M6MYTD1Y5YMAX

About Oscar Health

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Ticker
$OSCR
Sector
Finance
Primary listing
NYSE
Employees
2,305

Oscar Health Metrics

BasicAdvanced
$9.5B
16.14
$1.91
2.39
-

What the Analysts think about Oscar Health

Analyst ratings (Buy, Hold, Sell) for Oscar Health stock.
Analyst projections of the future price of Oscar Health stock.

Bulls say / Bears say

Oscar’s business is growing quickly: June membership reached 2.96 million, up 46% year on year, while second-quarter revenue rose to $4.88 billion from $2.86 billion. That gives the company a larger base over which to spread its costs. (Oscar Health)
Profitability is improving, and management raised its 2026 operating-earnings outlook in September to $600 million–$800 million, while lowering its expected medical loss ratio to 81%–82%. If these gains hold, Oscar could show that its pricing and cost controls work at scale. (SEC, Oscar Health)
Oscar sees room to grow beyond its current footprint: it plans to enter 400–600 more counties by 2029 and expand its potential reach from 9.6 million to 16 million lives. Its CHOICE and Lucie initiatives could also widen distribution and add fee-based revenue beyond insurance underwriting. (Oscar Health, Yahoo Finance)
Oscar remains highly exposed to federal support for ACA coverage: CMS subsidies represented 90% of direct policy premiums in the second quarter. The enhanced tax credits have expired, and Oscar says this has already made coverage unaffordable for some people and reduced marketplace participation. (SEC)
CMS programme-integrity reviews create a near-term membership headwind: Oscar expected 250,000–300,000 members to be retroactively disenrolled, and management said second-half churn could run at roughly twice its earlier pace. Fewer members could weigh on revenue even if the company’s annual outlook holds. (SEC, The Motley Fool)
Some of the strong improvement in Oscar’s medical loss ratio came from favourable prior-period reserve development, including $164 million in the second quarter. If that benefit does not recur, or claims and risk-adjustment estimates worsen, underlying earnings could be weaker than the headline results suggest. (Oscar Health)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.

Oscar Health Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Oscar Health Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Oscar Health

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.